Skip to main content
OpenTrials
Not yet recruiting

NCT Number: NCT07796984

Study of the Intracerebral Electrophysiological Signature in the Epileptic Patient

As part of the clinical management of certain severe, drug-resistant forms of epilepsy, it is necessary to implant electrodes in the brain to identify the epileptic network prior to potential neurosurgical resection of the source zones. This standardized procedure, known as Stereo-Electroencephalography (SEEG), was developed in France in the 1960s. The electrodes remain implanted for several days-typically two weeks-while awaiting spontaneous epileptic seizures. During this period, the patient remains hospitalized, and their electroencephalographic activity is recorded around the clock.

Patients can be asked to perform cognitive tasks (such as tasks involving memory, attention, vision, language, and decision-making) while awake or asleep; the results can then be correlated with the intracerebral electroencephalographic activity recorded simultaneously as part of their clinical care. This approach makes it possible to capture the electrophysiological signatures of specific cognitive processes, thereby enabling researchers to: 1) create a brain map of electrophysiological signatures, 2) improve standard models of cognitive function, and 3) study the dysfunction of these processes in epilepsy.

Not yet recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Electrophysiologie cérébrale, épilepsie, sommeil, Hôpital Pierre Paul Riquet

Toulouse, Oui, 31000, France

Location contact

Emeline Muller

CONTACT

[email protected]

0561778707 ext. +33

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient with drug-resistant focal epilepsy undergoing SEEG evaluation as part of the pre-surgical workup for epilepsy
  • Intellectual capacity sufficient to perform cognitive tasks, receive information about the study procedure, and understand the information sheet

Exclusion criteria

  • Patients already participating in another research project that prohibits participation in another study

Treatment and study plan

Cognitive tasks in the form of questionnaires

Other

During their hospitalization for SEEG, patients will perform cognitive tasks to assess memory, vision, attention, language, and decision-making.

Primary outcomes

  1. Construction of a database of electrophysiological signatures of various cognitive functions

    Time frame: 3 weeks after the inclusion

    Correlation of performance on a task involving a neurocognitive process with characteristics of brain activity recorded during the task (electrophysiological signature) using intracranial stereo-electroencephalography (SEEG) electrodes.

Secondary outcomes

  1. Evaluation of the impact of epilepsy on these electrophysiological signatures

    Time frame: 3 weeks after the inclusion

    Significant impact of the patient's epilepsy on the normal electrophysiological signature expected during certain cognitive processes.

  2. Determine whether a given brain region is dysfunctional in certain epileptic patients by comparing it with the atlas of normal physiological signatures.

    Time frame: 3 weeks after the inclusion

    Identification of a dysfunctional brain region in an epileptic patient if the electrophysiological signature differs significantly from that expected based on the atlas.

Study contacts

Contact information is provided by the study sponsor or research team.

Jonathan Curot, PHD

CONTACT

[email protected]

05 61 77 94 88 ext. +33

Sponsors and collaborators

Lead sponsor

University Hospital, Toulouse

Other

Registry information

Official study title

Study of the Intracerebral Electrophysiological Signature of Cognitive Processes and Functional Mapping in Patients With Drug-resistant Epilepsy

Acronym: ACTELIN 2

Important dates

Study start
2026
Primary completion
2031
Study completion
2031
First posted
Sep 1, 2026
Registry last updated
Sep 1, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.